Recent Advances in Gestational Diabetes Mellitus
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Endocrinology & Metabolism".
Deadline for manuscript submissions: closed (1 February 2021) | Viewed by 71164
Special Issue Editor
Special Issue Information
Dear Colleagues,
The incidence of gestational diabetes mellitus (GDM) and overt diabetes in pregnancy is rising globally. GDM represents an important modifiable risk factor for adverse pregnancy outcomes. GDM is also associated with negative long-term health outcomes for both mothers and offspring. There is still a lack of worldwide consensus on how to define GDM. Although much is known about GDM, evidence gaps persist at all points in translating the molecular understanding of GDM to efficacious therapies. For instance, more research is needed to find successful strategies to prevent GDM, on how to define GDM in early pregnancy, on additional biomarkers that can predict pregnancy complications, and on the long-term metabolic risk and optimal management of mother and infant after delivery. The scope of this Special Issue is to provide an overview of recent advances in the field of GDM. Therefore, researchers in the field of GDM are encouraged to submit an original article (no animal research) or review to this Special Issue (case reports and short reviews are not accepted).
Prof. Dr. Katrien Benhalima
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Gestational diabetes mellitus
- Screening
- Prevention
- Management
- Biomarkers
- Postpartum
- Overweight
- Type 2 diabetes mellitus
- Offspring
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.